10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001558370-23-008540`
Period End Date	20230331
Filing Date	20230508
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	tmb-20230331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 92 Income Statement 99 Cash Flow Statement 92

Balance Sheet 92 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$2.57M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$3.49M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$172.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$127.28M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Short-term available-for-sale investments	`ShortTermInvestments`	$74.46M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`ShortTermInvestments`	$29.91M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $3,491 and $2,568, respectively	`AccountsReceivableNetCurrent`	$194.55M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $3,491 and $2,568, respectively	`AccountsReceivableNetCurrent`	$216.41M	USD	Point-in-time
Inventories	`InventoryNet`	$141.12M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$169.46M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.92M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.86M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	156.64M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$605.56M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	157.34M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$571.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$223.57M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	156.64M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$223.24M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	157.34M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$97.98M	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$65.56M	USD	Point-in-time
Goodwill	`Goodwill`	$822.10M	USD	Point-in-time
Goodwill	`Goodwill`	$870.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$553.26M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$531.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$46.83M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$283.35M	USD	Point-in-time
Total assets	`Assets`	$2.29B	USD	Point-in-time
Total assets	`Assets`	$2.60B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$33.87M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$27.12M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$61.95M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$38.52M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.89M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.64M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$23.41M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$24.88M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$18.17M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$13.24M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.93M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$10.72M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$5.25M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$865.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$141.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$176.02M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$98.99M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$94.61M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$370.00M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$243.41M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$93.27M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$58.13M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$12.24M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.97M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 157,339,318 and 156,644,212, respectively	`CommonStockValue`	$1.57M	USD	Point-in-time
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 157,339,318 and 156,644,212, respectively	`CommonStockValue`	$1.57M	USD	Point-in-time
Additional paid-in capital(1)	`AdditionalPaidInCapitalCommonStock`	$652.47M	USD	Point-in-time
Additional paid-in capital(1)	`AdditionalPaidInCapitalCommonStock`	$715.05M	USD	Point-in-time
Retained earnings(1)	`RetainedEarningsAccumulatedDeficit`	$1.25B	USD	Point-in-time
Retained earnings(1)	`RetainedEarningsAccumulatedDeficit`	$1.12B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-73.55M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.20M	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.89B	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.70B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-759.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.71B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.89B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.60B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.29B	USD	Point-in-time

Income Statement 99 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$835.38M	USD	3 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$294.15M	USD	1 Quarter
Stock dividend stock spilt	`StockholdersEquityNoteStockSplitConversionRatio1`	4.00	pure	Point-in-time
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$817.37M	USD	3 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$290.38M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$88.92M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$270.26M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$261.23M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$91.98M	USD	1 Quarter
Gross margin	`GrossProfit`	$565.12M	USD	3 Qtrs
Gross margin	`GrossProfit`	$201.46M	USD	1 Quarter
Gross margin	`GrossProfit`	$202.16M	USD	1 Quarter
Gross margin	`GrossProfit`	$556.15M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$89.27M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$291.62M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$276.14M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$99.24M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$63.99M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$22.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$21.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$69.07M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$111.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$360.70M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$340.13M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$121.95M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$90.45M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$204.42M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$80.21M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$216.02M	USD	3 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$-21.68M	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$6.32M	USD	3 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$-15.00K	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$45.92M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$68.77M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$80.20M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$250.34M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$222.33M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$40.38M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$8.63M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$21.15M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$9.98M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$60.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$50.01M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$70.22M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$209.96M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$201.18M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$89.73M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-595.00K	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-9.34M	USD	3 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$179.00K	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$210.53M	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$60.74M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$209.78M	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$70.22M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$3.28M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.57M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-805.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-2.85M	USD	1 Quarter
Foreign currency translation reclassified to earnings with Eminence deconsolidation	`OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent`	$119.00K	USD	1 Quarter
Foreign currency translation reclassified to earnings with Eminence deconsolidation	`OtherComprehensiveIncomeLossReleaseOfForeignCurrencyTransactionAndTranslationFromSalePortionAttributableToParent`	$119.00K	USD	3 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$11.74M	USD	3 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$2.30M	USD	3 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-1.71M	USD	1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$7.18M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.81M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.57M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.17M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.62M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.33M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-6.96M	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-33.00K	USD	3 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$26.00K	USD	3 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-1.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.15M	USD	3 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.65M	USD	3 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.57M	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.33M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$212.67M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$211.43M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$71.79M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$65.07M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.34	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$1.34	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.39	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.45	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.43	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.30	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.28	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.37	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	156.90M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.07M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.09M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.31M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	161.62M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	163.87M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	164.29M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	161.77M	shares	3 Qtrs

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net earnings, including noncontrolling interest	`ProfitLoss`	$60.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$50.01M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$70.22M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$209.96M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$201.18M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$89.73M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.20M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$80.31M	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.60M	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$400.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$7.89M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-22.65M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$41.31M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$33.78M	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-10.35M	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-20.60M	USD	3 Qtrs
Contingent consideration payments - operating	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.30M	USD	3 Qtrs
(Gain) Loss on investment, net	`GainOnSaleOfInvestments`	$37.18M	USD	3 Qtrs
Fair value adjustment on available-for-sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-1.15M	USD	3 Qtrs
Fair value adjustment on available-for-sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-15.57M	USD	3 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	$546.00K	USD	3 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	-	USD	3 Qtrs
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	$18.71M	USD	3 Qtrs
Gain on sale of Eminence	`GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee`	-	USD	3 Qtrs
Gain on sale of Eminence	`GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee`	$11.68M	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$1.43M	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$-974.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$296.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$549.00K	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$20.77M	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$60.93M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$28.82M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$16.03M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$5.56M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.58M	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-5.65M	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$11.23M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$2.06M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-22.76M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-9.21M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.85M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$171.00M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$222.56M	USD	3 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$29.16M	USD	3 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$26.05M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$48.00M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$20.50M	USD	3 Qtrs
Proceeds from sale of CCXI investment	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$73.22M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.41M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.34M	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$101.18M	USD	3 Qtrs
Proceeds from sale of Eminence	`ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries`	$17.82M	USD	3 Qtrs
Investment of forward purchase contract	`PaymentsForDerivativeInstrumentInvestingActivities`	$25.00M	USD	3 Qtrs
Investment in Wilson Wolf	`PaymentsToAcquireEquityMethodInvestments`	$232.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.28M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-260.89M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$37.65M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$37.69M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$21.40M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$68.35M	USD	3 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$102.13M	USD	3 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$19.56M	USD	3 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$90.00M	USD	3 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$619.66M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$505.66M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$172.38M	USD	3 Qtrs
Contingent consideration payments - financing	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$700.00K	USD	3 Qtrs
Contingent consideration payments - financing	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	3 Qtrs
Taxes paid on RSUs and net share settlements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$28.85M	USD	3 Qtrs
Taxes paid on RSUs and net share settlements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.41M	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$788.00K	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.46M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-177.12M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$46.84M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-2.23M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-5.42M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-38.27M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-45.28M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$160.82M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$127.28M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$172.57M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$160.82M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$127.28M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$172.57M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$22.96M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$62.58M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.52M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.77M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.